Company news
Heron Therapeutics, Inc. news in 2023
Heron Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.
Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial Guidance
November 13, 2023
Heron Therapeutics to Report Third Quarter 2023 Financial Results On Tuesday, November 14, 2023
November 6, 2023
Heron Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Updates
August 13, 2023
Heron Therapeutics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023
August 6, 2023
Heron Therapeutics Announces $30 Million Private Placement Financing
July 23, 2023
Heron Therapeutics Announces Cost Reduction Plan and Restructuring
July 23, 2023
Heron Therapeutics Announces Appointment of Ira Duarte as Chief Financial Officer
June 22, 2023
Heron Therapeutics Announces Appointment of William Forbes, Pharm.D. as Chief Development Officer
June 11, 2023
Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2023 and Highlights Recent Corporate Updates
May 10, 2023
Heron Therapeutics to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
May 3, 2023
Heron Therapeutics Announces Commercial Leadership Changes
April 19, 2023
Heron Therapeutics Announces Presentation at 22nd Annual Needham Virtual Healthcare Conference
April 16, 2023
Heron Therapeutics Announces New CEO and Board Chairman
April 2, 2023
Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Highlights Recent Corporate Updates
March 22, 2023
Heron Therapeutics Announces Centers for Medicare & Medicaid Services (CMS) Granted Pass-through Payment Status for APONVIE™, Effective April 1, 2023
March 12, 2023
Heron Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 23, 2023
March 9, 2023
Heron Therapeutics Announces U.S. Commercial Launch of APONVIE™ for the Management of Postoperative Nausea and Vomiting in Adults
March 5, 2023
Heron Therapeutics Announces Presentation at 43rd Annual Cowen Healthcare Conference
February 26, 2023
Heron Therapeutics Enters into Cooperation Agreement with Rubric Capital and Velan Capital
February 21, 2023
Heron Therapeutics Highlights Progress in Acute Care and Oncology Care Franchises
January 8, 2023
Calls in 2023
- Heron Therapeutics (NASDAQ:HRTX) Q3 2023 Earnings Call
Nov 14, 2023
Transcript - Heron Therapeutics (NASDAQ:HRTX) Q2 2023 Earnings Call
Aug 14, 2023
Transcript - Heron Therapeutics (NASDAQ:HRTX) Q1 2023 Earnings Call
May 11, 2023
Transcript - Heron Therapeutics (NASDAQ:HRTX) Q4 2022 Earnings Call
Mar 23, 2023
Transcript